Whilst this may result in less robust therapeutic effects, a tolerable lower dose that patients can maintain long-term often proves more beneficial than a higher dose that leads to discontinuation
Any consideration of investigational approaches should occur only within the context of clinical trials or with explicit acknowledgment of the limited evidence base and careful risk-benefit assessment tailored to your specific clinical circumstances
| GoodRx
To establish the T2DM model, after 8 weeks of HFD (10% lard, 20% sucrose, 2.5% cholesterol, 1% bile salt, and 66.5% regular diet), rats received the intraperitoneal (i.p.) injection of 35 mg/kg STZ (Sigma) after overnight fasting
A number of studies have shown GLP-1s to improve depression symptoms, however some users report more depressive symptoms
Protein breakdown in the body stimulates the small intestine to release more GLP-1